Cited by 877Immunotherapy and Immune ResponsesT-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers

The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes

Open access

Munn, David H., Sharma, Madhav D., Hou, Deyan, Baban, Babak, Lee, Jeffrey R., Antonia, Scott J., Messina, Jane L., Chandler, Phillip, Koni, Pandelakis A., Mellor, Andrew L.·2004·Journal of Clinical Investigation

DOI 10.1172/jci21583

Open this paper in CoChat — free account Open PDF

Abstract

One mechanism contributing to immunologic unresponsiveness toward tumors may be presentation of tumor antigens by tolerogenic host APCs.We show that mouse tumor-draining LNs (TDLNs) contained a subset of plasmacytoid DCs (pDCs) that constitutively expressed immunosuppressive levels of the enzyme indoleamine 2,3-dioxygenase (IDO).Despite comprising only 0.5% of LN cells, these pDCs in vitro potently suppressed T cell responses to antigens presented by the pDCs themselves and also, in a dominant fashion, suppressed T cell responses to third-party antigens presented by nonsuppressive APCs.Adoptive transfer of DCs from TDLNs into naive hosts created profound local T cell anergy, specifically toward antigens expressed by the transferred DCs.Anergy was prevented by targeted disruption of the IDO gene in the DCs or by administration of the IDO inhibitor drug 1-methyl-D-tryptophan to recipient mice.Within the population of pDCs, the majority of the functional IDO-mediated suppressor activity segregated with a novel subset of pDCs coexpressing the B-lineage marker CD19.We hypothesize that IDO-mediated suppression by pDCs in TDLNs creates a local microenvironment that is potently suppressive of host antitumor T cell responses.Nonstandard abbreviations used: indoleamine 2,3-dioxygenase (IDO); 1-methyl-D-tryptophan (1MT); mixed leukocyte reaction (MLR); plasmacytoid DC (pDC); regulatory T cell (Treg); T cell receptor (TCR); tumor-draining LN (TDLN). Conflict of interest:The authors have declared that no conflict of interest exists.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci21583

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

T cell receptor antagonist peptides induce positive selection.
Hogquist, K., Jameson, S., Heath, W., Howard, J. L., Bevan, M., & Carbone, F. (1994) · Cell · doi:10.1016/0092-8674(94)90169-4 · Cited by 3,252
Tolerogenic Dendritic Cells
Steinman, R. M., Hawiger, D., & Nussenzweig, M. C. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141040 · Cited by 3,162
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
Dranoff, G., Jaffee, E. M., Lazenby, A., Golumbek, P. T., Levitsky, H., Brose, K., Jackson, V., Hamada, H., Pardoll, D. M., & Mulligan, R. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3539 · Cited by 2,820
Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I. E., Conway, S. J., Marshall, B., Brown, C. C., & Mellor, A. L. (1998) · Science · doi:10.1126/science.281.5380.1191 · Cited by 2,589
Self-citation
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
Uyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., & Van den Eynde, B. J. (2003) · Nature Medicine · doi:10.1038/nm934 · Cited by 2,305
Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism
Munn, D. H., Shafizadeh, E., Attwood, J. T., Bondarev, I. E., Pashine, A., & Mellor, A. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.9.1363 · Cited by 1,640
Self-citation
Modulation of tryptophan catabolism by regulatory T cells
Fallarino, F., Grohmann, U., Hwang, K. W., Orabona, C., Vacca, C., Bianchi, R., Belladonna, M. L., Fioretti, M. C., Alegre, M., & Puccetti, P. (2003) · Nature Immunology · doi:10.1038/ni1003 · Cited by 1,375
CTLA-4–Ig regulates tryptophan catabolism in vivo
Grohmann, U., Orabona, C., Fallarino, F., Vacca, C., Calcinaro, F., Falorni, A., Candeloro, P., Belladonna, M. L., Bianchi, R., Fioretti, M. C., et al. (2002) · Nature Immunology · doi:10.1038/ni846 · Cited by 1,204
Commitment to the B-lymphoid lineage depends on the transcription factor Pax5
Nutt, S. L., Heavey, B., Rolink, A. G., & Busslinger, M. (1999) · Nature · doi:10.1038/44076 · Cited by 1,179
Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens
Huang, A. Y.-C., Golumbek, P. T., Ahmadzadeh, M., Jaffee, E. M., Pardoll, D. M., & Levitsky, H. I. (1994) · Science · doi:10.1126/science.7513904 · Cited by 1,159

Flagged first, then by citations

Show all 85 references

Research works printed but not linked: 2

Cuenca, 2003, Cancer Res., 63, 9007
Almand, 2000, Clin. Cancer Res., 6, 1755

Sorted by citations

Items 701–800 of 877

Recognition of Carcinoembryonic Antigen Peptide and Heteroclitic Peptide by Peripheral Blood T Lymphocytes
Brown, M. E., Miao, H., & McKee, M. D. (2007) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31802b5005 · Cited by 5
Experimental and clinical evidence in favour of an effective immune stimulation in ER-positive, endocrine-dependent metastatic breast cancer
Nicolini, A., Rossi, G., & Ferrari, P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1225175 · Cited by 5
Unleashing the therapeutic potential of tumor-draining lymph nodes: spotlight on bladder cancer
Yang, X., Wu, X., Hao, X., Li, T., Guo, H., & Yang, R. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-024-05864-7 · Cited by 4
Immunosuppressive Factor Blockade in Dendritic Cells via siRNAs Results in Objective Clinical Responses
Sioud, M., Mobergslien, A., & Sæbøe‐Larssen, S. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1538-5_16 · Cited by 4
Dendritic Cell Biology: Subset Heterogeneity and Functional Plasticity
Soumelis, V., Liu, Y., & Gilliet, M. F. (2007) · Springer eBooks · doi:10.1007/978-0-387-33785-2_1 · Cited by 4
Tumor immune evasion mediated by IDO
Munn, D. H. (2006) · Update on Cancer Therapeutics · doi:10.1016/j.uct.2006.05.009 · Cited by 4
Self-citation
Immuno-modulatory Role of Indoleamine 2, 3-Dioxygenase in Allogeneic Islet and Skin Transplantation
Gill, P., Jalili, R. B., & Ghahary, A. (2013) · Research in Immunology An International Journal · doi:10.5171/2013.235635 · Cited by 4
Role of IDO expression in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy
Takasu, C., Nishi, M., Yoshikawa, K., Tokunaga, T., Nakao, T., Kashihara, H., Wada, Y., Yoshimoto, T., Okikawa, S., Yamashita, S., et al. (2022) · BMC Cancer · doi:10.1186/s12885-022-10357-1 · Cited by 4
Monitoring of tryptophan as a biomarker for cancerous cells in Terahertz (THz) sensing
Altan, H., Özek, N. Ş., Gök, S., Ozyurt, I., & Severcan, F. (2016) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2218032 · Cited by 4
Virus‐based immunotherapy of cancer: what do we know and where are we going?
Sørensen, M. R., & Thomsen, A. R. (2007) · Apmis · doi:10.1111/j.1600-0643.2007.00802.x · Cited by 4
Prognostic and predictive value of IDO expression in metastatic melanoma treated with Ipilimumab
von Bubnoff, D., Schmitt, C., Goldinger, S. M., Schadendorf, D., Kähler, K. C., Hafner, C. M., Kramer, N., Fröhlich, W., Dummer, R., Berking, C., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0321937 · Cited by 3
Calcium-pterin suppresses mitogen-induced tryptophan degradation and neopterin production in peripheral blood mononuclear cells
Winkler, C., Schroecksnadel, K., Moheno, P. B. B., Meerbergen, E., Schennach, H., & Fuchs, D. (2006) · Immunobiology · doi:10.1016/j.imbio.2006.08.002 · Cited by 3
The differentiation of new human CD303+ Plasmacytoid dendritic cell subpopulations expressing CD205 and/or CD103 regulated by Non-Small-Cell lung cancer cells
Zhong, Q., Lu, Y. C., Xu, W., Rong, Z., Xu, C., Qin, L., Chen, X., & Zhou, F. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107983 · Cited by 3
Unleashing the Therapeutic Potential of Dendritic and T Cell Therapies Using RNA Interference
Sioud, M. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0290-4_15 · Cited by 3
Recent Advances in Hematopoietic Stem Cell Transplantation and Perspectives of RNAi Applications
Fløisand, Y., & Sioud, M. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-657-3_30 · Cited by 3
A novel cell-surface protein CSP82 on bone marrow stem cells and a cytosolic phosphoprotein DP58 (ankyrinRD 34B) are involved in promyeloid progenitor induction
Al-Shaibi, N., & Ghosh, S. K. (2009) · Cellular Immunology · doi:10.1016/j.cellimm.2009.05.006 · Cited by 3
Cancer and Infectious Causes
Smith, A., Oertle, J. C., III, & Prato, D. (2014) · Open Journal of Medical Microbiology · doi:10.4236/ojmm.2014.43019 · Cited by 3
Potential roles of self-reactive T cells in autoimmunity: lessons from cancer immunology
Andersen, M. H. (2014) · Immunologic Research · doi:10.1007/s12026-014-8559-3 · Cited by 3
Nanotechnology for Cancer Vaccine Delivery
Hamdy, S. I., Alshamsan, A., & Samuel, J. (2008) · Springer eBooks · doi:10.1007/978-0-387-77668-2_17 · Cited by 3
Evaluation of the expression of the immunosuppressive enzyme – indoleamine 2,3-dioxygenase in ovarian cancer tissue
Rogala, E., Nowicka, A., Bednarek, W., Barczyński, B., Piekarczyk, W., Klimek, K., Zakrzewski, M., & Kotarski, J. (2013) · Menopause Review/Przegląd Menopauzalny · doi:10.5114/pm.2013.36587 · Cited by 3
Cancer Immunology
Pardoll, D. M. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00006-0 · Cited by 4
Dendritic Cells in Tumor-Draining Lymph Nodes
Cochran, A. J., Huang, R., Itakura, E., Lee, J. H., & Molenkamp, B. G. (2009) · Springer eBooks · doi:10.1007/978-0-387-88611-4_20 · Cited by 3
Self-citation
Targeting Overexpressed IDO in Stromal Cells as a Potential Therapeutic Strategy in Multiple Myeloma
Ebina, T., Ri, M., Marumo, Y., Nakamura, T., Sasaki, H., Oshima, Y., Nakashima, T., Hagiwara, S., Asano, A. T., Kinoshita, S., et al. (2025) · Cancer Science · doi:10.1111/cas.70255 · Cited by 2
Melanoma Immunotherapy: Overcoming Obstacles to Augment Anti-Tumor Immune Responses
Hargadon, K. M. (2013) · Journal of Cosmetics Dermatological Sciences and Applications · doi:10.4236/jcdsa.2013.32a002 · Cited by 2
Indoleamine 2,3-Dioxygenase in Human Hematopoietic Stem Cell Transplantation
Jürgens, B., Raberger, J., Fuchs, D., & Heitger, A. (2010) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s4076 · Cited by 2
Indoleamine 2,3-Dioxygenase (IDO) and Cancerous Cells
Safdarian, A. R., Farhangnia, P., & Rezaei, N. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_72-1 · Cited by 2
The Role of L-Tryptophan Kynurenine Pathway Metabolism in Various Infectious Diseases: Focus on Indoleamine 2,3-Dioxygenase 1
Murakami, Y., Ito, H., & Saito, K. (2015) · Molecular and integrative toxicology · doi:10.1007/978-3-319-15630-9_5 · Cited by 2
Cancer Immunotherapy with Vaccines and Checkpoint Blockade
Pardoll, D. M. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4066-6.00052-4 · Cited by 2
Strategies of designing lymph nodes-targeting nanoparticles for cancer immunotherapy
Huang, Z., Fu, F., Deng, C., Wu, S., Huang, M., Sha, X., Wei, M. Q., Zhang, Z., & Zhang, Y. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.111993 · Cited by 2
Indoleamine 2,3-dioxygenase and regulatory dendritic cells contribute to the allograft protection induced by infusion of donor-specific splenic stromal cells
Liu, L., Duan, L., Gong, M., Dai, H., Gong, Q., Zheng, F., Tan, Z., Wang, C., Gong, F., & Fang, M. (2010) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.53 · Cited by 2
Immunomodulating Effect of Ethyl Pyruvate on Nonsyngenic Transplanted Tumor in Mice
Богданова, Л. А., Morozkova, T. S., Каледин, В. И., Nikolin, V. P., & Попова, Н. А. (2013) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-013-2252-8 · Cited by 2
Preventing Hyperglycemia and Tissue Injury in Diabetes: The Dynamic Role of 2,3 Indoleamine Dioxygenase (IDO) in Diabetes and Its Complications
Bartoli, M., Lamoke, F., & Baban, B. (2013) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-94-007-5971-8_10 · Cited by 2
Self-citation
Role of IDO in Dendritic Cell Differentiation and Function in Cancer
Popov, A., & Schultze, J. L. (2009) · Springer eBooks · doi:10.1007/978-0-387-88611-4_15 · Cited by 2
Role of the Immune Tolerance-Inducing Molecule Indoleamine 2,3-Dioxygenase in Gynecologic Cancers
Tanizaki, K. I. Y. (2013) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.s13-001 · Cited by 2
Current Trends in Immuno-Oncology
Vanteddu, V. G., Bawari, S., & Patel, T. D. (2022) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/1871525720666220829142225 · Cited by 2
Hsp60 e imunorregulação: estratégias para identificação de peptídeos imunorreguladores
Martello, F. G. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2010.tde-15042010-110232 · Cited by 2
Differential targeting of tryptophan catabolism in tumors and in tumor-draining lymph nodes by stereoisomers of the IDO inhibitor 1-methyl-tryptophan
Muller, A. J., Metz, R. A., & Prendergast, G. C. (2007) · International Congress Series · doi:10.1016/j.ics.2007.07.042 · Cited by 3
Mechanism of Trichinella spiralis-mediated CD4+ T cell functional imbalance via IDO-dependent tryptophan metabolism
Yu, W., Yuan, X., Li, W., & Han, C. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116517 · Cited by 1
Expressão da enzima indoleamina-2,3-dioxigenase em truta arco-íris (Oncorhynchus mykiss)
Cardoso, F. C., Bruno, C. E. M., Ramos, C. C., Conrado, A. L. V., Tabata, Y. A., Ferrão, J. S. P., & Kfoury, J. R. (2015) · Pesquisa Veterinária Brasileira · doi:10.1590/s0100-736x2015001000008 · Cited by 1
Mechanisms of indoleamine 2,3-dioxygenase (IDO)-mediated immunosuppression
Wu, Y., Wang, M., & Yu, B. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-14064-8.00042-4 · Cited by 1
Tumor draining lymph nodes in non-small cell lung cancer: underrecognized role in biomarker discovery and therapeutic innovation
Bain, A. M., DeMaio, A. J., Velez, A., Tsay, J.-C. J., & Sterman, D. H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1781682 · Cited by 1
A Review of Aryl Hydrocarbon Receptor–Mediated Immune Regulation in Cutaneous Squamous Cell Carcinoma Progression
Han, H., Dong, Q., Zhang, Z., Li, S., Zhang, H., Wang, X., Bai, J., Shi, L., Fu, X., Zheng, K., et al. (2026) · ImmunoTargets and Therapy · doi:10.2147/itt.s601152 · Cited by 1
Atorvastatin pre-exposure in hypercholesterolemia remedies 27HC mediated dendritic cell dysfunctions in triple-negative breast cancer
Choudhury, P. R., Chakravarti, M., Bera, S., Arora, P., Sultana, J., Khan, M. A., Biradar, R., Guha, A., Dhar, S., Ghosh, I., et al. (2026) · Molecular Therapy Oncology · doi:10.1016/j.omton.2026.201250 · Cited by 1
Cancer Immune Modulation and Immunosuppressive Cells: Current and Future Therapeutic Approaches
Sasso, M. S., Bronte, V., & Marigo, I. (2014) · Advances in delivery science and technology · doi:10.1007/978-3-319-08084-0_7 · Cited by 1
IDO in Immune Escape
Muller, A. J., Smith, C., Metz, R. A., & Prendergast, G. C. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394296-8.00032-4 · Cited by 1
Inflammatory programming and immune modulation in cancer by IDO
Smith, C., & Prendergast, G. C. (2013) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/51878 · Cited by 1
Immunoprotective role of IDO in engraftment of allogeneic skin substitutes
Chavez-Munoz, C. I., Hartwell, R., Jalili, R. B., & Ghahary, A. (2010) · Expert Review of Dermatology · doi:10.1586/edm.10.53 · Cited by 1
Negative Regulators in Cancer Immunology and Immunotherapy
Zimmermann, W., & Kammerer, R. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-980-2_11 · Cited by 1
Dendritic Cell Maturation Versus Polarization in Tumor Escape
Lipscomb, M. W., Storkus, W. J., & Wesa, A. K. (2009) · Springer eBooks · doi:10.1007/978-0-387-88611-4_18 · Cited by 1
Relative indoleamine 2,3-dioxygenase transcript level concerning anti-HBs titers in response to HBV vaccination in hemodialysis patients
Grzegorzewska, A. E., Frycz, B. A., Winnicka, H., Warchol, W. J., & Jagodziński, P. P. (2018) · Expert Review of Vaccines · doi:10.1080/14760584.2018.1527691 · Cited by 1
The Expression Profile of mRNA and tRNA Genes in Splenocytes and Neutrophils after In Vivo Delivery of Antitumor Short Hairpin RNA of Indoleamine 2,3- Dioxygenase
Huang, M., Hsu, Y., Yeh, I., Liu, K., & Yen, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186703 · Cited by 1
Cancer Immunology
Pardoll, D. M. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06694-8.50009-9 · Cited by 1
Tumormikromilieu des Melanoms – Einfluss moderner Therapien
Sirokay, J. D., & Mauch, C. (2022) · Die Dermatologie · doi:10.1007/s00105-022-05078-2 · Cited by 1
Indoleamine 2,3-Dioxygenase Amino Acid Metabolism and Tumour-Associated Macrophages: Regulation in Cancer-Associated Inflammation and Immune Escape
Prendergast, G. C., Metz, R. A., Chang, M. Y., Smith, C., Muller, A. J., & Ostrand‐Rosenberg, S. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0662-4_7 · Cited by 1
Immune Escape: Role of Indoleamine 2,3-Dioxygenase in Tumor Tolerance
Katz, J. B., Muller, A. J., Metz, R. A., & Prendergast, G. C. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0170-5_15 · Cited by 1
Targeted siRNA Delivery Methods for RNAi-Based Therapies
Chen, D. (2013) · Scholarship@Western (Western University) · Cited by 1
indoleamine 2,3-dioxygenase
Soliman, H. H. (2014) · Springer eBooks · doi:10.1007/978-1-4614-6613-0_134-1 · Cited by 1
Role of Kynurenine Pathway in Cancer Biology
Mowat, C. G. (2015) · Springer eBooks · doi:10.1007/978-3-319-11870-3_21 · Cited by 1
Pathogenesis of B-cell post-transplant lymphoproliferative disorders and HIV-associated B-cell lymphomas
Ibrahim, H. (2010) · doi:10.25560/6154 · Cited by 1
Cells of the Immune System
Parker, G. A. (2017) · Molecular and integrative toxicology · doi:10.1007/978-3-319-47377-2_2 · Cited by 1
IDO/TDO Inhibition in Cancer
Prendergast, G. C., Malachowski, W. J., Mondal, A., Scherle, P., & Muller, A. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-62431-0_17 · Cited by 1
Molecular Pathways in Antigen-Presenting Cells Involved in the Induction of Antigen-specific T-cell Tolerance
Woods, D. M., Laino, A. S., Villagra, A., & Sotomayor, E. M. (2014) · Springer eBooks · doi:10.1007/978-1-4899-8056-4_15 · Cited by 1
Cancer Immunology
Tseng, D., Schultz, L. M., Pardoll, D. M., & Mackall, C. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00006-2 · Cited by 2
Exploring the Role of the Lymphatic System in Immune Regulation: Implications for Autoimmunity, Cancer, and Infection
Norouzian, M., & Abdi, S. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1002802 · Cited by 1
IDO Pathway
Munn, D. H., & Mellor, A. L. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394296-8.00033-6 · Cited by 1
Self-citation
Dendritic Cells in Human Cancer
Carlos, C. A., & Finn, O. J. (2006) · Wiley eBooks · doi:10.1002/9783527619696.ch51 · Cited by 1
Immunosuppressive Factors in Cancer
Moss, J. E., Metz, C. N., & Bucala, R. (2006) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.200400129 · Cited by 1
Role of Regulatory Subsets During Aging
Trzonkowski, P. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9063-9_18 · Cited by 1
Regulation of T Cell-Dependent Humoral Immunity Through CD137 (4-1BB) Mediated Signals
Mittler, R. S., Niu, L., Hewes, B., & Foell, J. L. (2007) · Springer eBooks · doi:10.1007/0-387-32829-7_5 · Cited by 1
Endometrial Cancer: Indoleamine 2,3-Dioxygenase as a Prognostic Indicator
Ino, K., Yamamoto, E., Shibata, K., Kajiyama, H., Nawa, A., & Kikkawa, F. (2009) · Springer eBooks · doi:10.1007/978-90-481-2918-8_24 · Cited by 1
Preparation and Functional Analysis of Tumor‐Infiltrating Stroma Cells Using Bone Marrow Chimera Mice
Ishigaki, H., Yamamoto, Y., Ishida, H., Kajino, K., Itoh, Y., Fujiyama, Y., & Ogasawara, K. (2006) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2006.tb03830.x · Cited by 1
The Tumor Microenvironment
Coukos, G., & Conejo-Garcia, J. R. (2006) · Humana Press eBooks · doi:10.1385/1-59745-011-1:285 · Cited by 1
Targeted BRAF inhibitors: Immunological effects and combination with immunotherapy
Cameron, A. M. (2015) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17013803 · Cited by 1
MOLECULAR REGULATION OF THE TUMOR KILLING ACTIVITY OF DENDRITIC CELLS
Hanke, N. T. (2012) · UA Campus Repository (The University of Arizona) · Cited by 1
Dendritic Cells and Coregulatory Signals: Immune Checkpoint Blockade to Stimulate Immunotherapy
Pardoll, D. M. (2007) · Elsevier eBooks · doi:10.1016/b978-012372551-6/50078-x
Developmental and cholera toxin-induced alterations in the expression of intracellular signalling molecules
Zenić, L. (2013) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Dendritic Cells are Both Targets and Initiators of Peripheral Immune Tolerance to Self
Farkas, A. M. (2013) · D-Scholarship@Pitt (University of Pittsburgh)
The Use of Human Dendritic Cell Subsets in Cancer Vaccines
Sweere, J. M. (2011) · Utrecht University Repository (Utrecht University)
Development of Vaccine Therapy for Pancreas Cancer
Le, D. T., Jaffee, E. M., & Laheru, D. A. (2008) · Springer eBooks · doi:10.1007/978-0-387-69252-4_41
Nível de expressão tumoral da indoleamine 2,3-dioxigenase (IDO) como marcador biológico e preditor de metástase em pacientes com tumor carcinoide típico broncopulmonar
Day, A. A. R. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2011.tde-24022012-162815
pDC: From Plasmacytoid Dendritic Cell Precursorsto Professional Type 1 Interferon‐producing Cells
Liu, Y., Kanzler, H., Wang, Y., Wang, Y., Gilliet, M. F., Cao, W., & Ito, T. (2006) · Wiley eBooks · doi:10.1002/9783527619696.ch13
The Role of the Integrated Stress Response Kinase Gcn2 in Cell Cycle Regulation and Tumorigenesis
Lehman, S. L. (2015) · ScholarlyCommons (University of Pennsylvania)
Immunomodulatory role of flagellin in antigen-presenting cells
Vicente-Suarez, I. (2007) · Digital Commons - University of South Florida (University of South Florida)
Human Prostate Cancer Infiltrating Lymphocytes: Raft Microdomains, Signaling and Activation in Organ Cultures
Viola, A. (2006)
Signaling Pathways in Antigen-Presenting Cells Involved in the Induction of Antigen-Specific T-Cell Tolerance
Vicente-Suarez, I., Villagra, A., & Sotomayor, E. M. (2007) · Springer eBooks · doi:10.1007/978-0-387-69118-3_9
Ethanol Exposure and Dendritic Cell Function
Lau, A. H. (2006) · D-Scholarship@Pitt (University of Pittsburgh)
Synthesis, Molecular and Crystal Structure Analysis of 1-(4-Methylbenzenesulfonyl)indole-3-carbaldehyde and DFT Investigation of Its Rotational Conformers
Zukerman-Schpector, J., Madureira, L. S., Wulf, G. D., Stefani, H. A., Vasconcelos, S. N. S., Ng, S. W., & Tiekink, E. R. T. (2014) · Molecules · doi:10.3390/molecules19021990
Profile of regulatory T cells and interferon γ secretion in the tumor-draining lymph node from mouse Hepa1–6 cells
Wang, L.-K., Kuang, M., Hua, Y., He, Q., Chen, B., Wang, Y., & Peng, B. (2013) · Journal of Surgical Research · doi:10.1016/j.jss.2013.02.001
Human Tumor Antigen MUC1 as an Inducer of Dendritic Cell Migration and Distorted Maturation
Carlos, C. A. (2005) · D-Scholarship@Pitt (University of Pittsburgh)
Recipient dendritic cells dictate allograft fate
Divito, S. J. (2009) · D-Scholarship@Pitt (University of Pittsburgh)
Regulation of the multifaceted functions of human plasmacytoid dendritic cells: a polyphonic policy
Jachimowski, L. C. M. (2015) · UvA-DARE (University of Amsterdam)
261. Antigen-Specific Tolerance Induction by Transcriptional Targeting of Dendritic Cells with a Novel Lentiviral Vector
Dresch, C. (2007) · Molecular Therapy · doi:10.1016/s1525-0016(16)44467-9
Dendritic Cells for Cancer Immunotherapy
Larmonier, N., & Katsanis, E. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-417-3_11
Clinical implications and genetic regulation of indoleamine 2,3-dioxygenase serum activity
Raitala, A. (2009) · Tampere University Institutional Repository (Tampere University)
Home Genes Leukemias Tumors Cancer prone Deep Insight Case Reports Portal Journals Teaching X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA
Journal, A., Turhan, A. G., Kontos, C. K., Thomadaki, H., & Scorilas, A. (2009)
Critical appraisal of the current status of dendritic cell based therapy
Tirapu, I., Huarte, E., Alfaro, C., Arina, A., Murillo, O., Inogés, S., Bendandi, M., Mazzolini, G. D., & Melero, I. (2005)
Offer a Superior Survival Advantage in Myeloid Rather than Plasmacytoid Cells Based Vaccines that Utilize - Dendritic Cell
Lesniak, M. S., Han, Y., Tobias, A. L., Zhang, L., Qiao, J., Ahmed, A. U., Balyasnikova, I. V., Dey, M., Chang, A. L., & Miska, J. M. (2015)
Borrelidin, a threonyl-tRNA synthetase inhibitor, is a potent immunosuppressive and anti-inflammatory agent
Ogloff, N. (2013) · cIRcle (University of British Columbia) · doi:10.14288/1.0072670
Mechanisms of selective immunosuppressive effects of indoleamine 2, 3-dioxygenase and borrelidin
Habibi, D. (2011) · cIRcle (University of British Columbia) · doi:10.14288/1.0072044
P032. Indoleamine 2,3 dioxygenase
Speeckaert, R., van Geel, N., Lambert, J., Haspeslagh, M., Gele, M. V., Vermaelen, K. Y., Thielemans, K., Neyns, B., Roche, N. A., Rottey, S., et al. (2011) · Melanoma Research · doi:10.1097/01.cmr.0000399493.94753.2f

Authors: Munn, D. H., Sharma, M. D., Hou, D., Baban, B., Lee, J. R., Antonia, S. J., Messina, J. L., Chandler, P., Koni, P. A., & Mellor, A. L.
Affiliations: Augusta University (US)
University of South Florida (US)
Corresponding author: Munn, David H.
ORCID: Munn, David H.
Sharma, Madhav D.
Baban, Babak
Antonia, Scott J.
Messina, Jane L.
Koni, Pandelakis A.
Mellor, Andrew L.
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2004-07-15
Volume: 114
Issue: 2
Pages: 280-290
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci21583
OpenAlex: W2143565660
Cited by: 852
References: 85
Citations by year: 2026: 13 · 2025: 12 · 2024: 24 · 2023: 15 · 2022: 32 · 2021: 37 · 2020: 34 · 2019: 29 · 2018: 31 · 2017: 40 · 2016: 27 · 2015: 45 · 2014: 38 · 2013: 53 · 2012: 39
FWCI: 19.19
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed (publishedVersion)
Funders: Carlos and Marguerite Mason Trust
National Institutes of Health
National Cancer Institute (R01CA096651, R01 CA103220)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD041187)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords: indoleamine 2,3-dioxygenase, plasmacytoid dendritic cells, tumor-draining lymph nodes, immunosuppression, T cell anergy, tumor antigen presentation, CD19, 1-methyl-D-tryptophan, antitumor immunity, regulatory T cells, mixed lymphocyte reaction
MeSH terms: Animals, Antigen-Presenting Cells, Dendritic Cells, Female, Humans, Immunosuppression Therapy, Lymph Nodes, Lymphocyte Activation, Mice, Inbred Strains, Neoplasms, Random Allocation, T-Lymphocytes, Tryptophan Oxygenase, Survival Rate, Mice, Knockout, Antigens, CD19, Adoptive Transfer, CD11c Antigen, Indoleamine-Pyrrole 2,3,-Dioxygenase, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks